Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Mander

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P Mander
Statistical Methods in Medical Research|December 20, 2011
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expectedJames M S Wason, Adrian P Mander
Pharmaceutical Statistics|July 29, 2024
Efficient Study Design and Analysis of Longitudinal Dose-Response Data Using Fractional PolynomialsBenjamin F Hartley, Dave Lunn, Adrian P Mander
Journal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Trials|December 4, 2019
Sample size re-estimation in crossover trials: application to the AIM HY-INFORM studyJulie Wych, Michael J Grayling, Adrian P Mander
Trials|September 19, 2014
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?James M S Wason, Lynne Stecher, Adrian P Mander
Plos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Clinical Trials (London, England)|June 28, 2017
Group sequential designs for stepped-wedge cluster randomised trialsMichael J Grayling, James Ms Wason, Adrian P Mander
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 19, 2019
A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity dataGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of Biopharmaceutical Statistics|June 2, 2012
Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomesJames M S Wason, Adrian P Mander
Statistical Methods in Medical Research|December 20, 2011
The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expectedJames M S Wason, Adrian P Mander
Pharmaceutical Statistics|July 29, 2024
Efficient Study Design and Analysis of Longitudinal Dose-Response Data Using Fractional PolynomialsBenjamin F Hartley, Dave Lunn, Adrian P Mander
Journal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Trials|December 4, 2019
Sample size re-estimation in crossover trials: application to the AIM HY-INFORM studyJulie Wych, Michael J Grayling, Adrian P Mander
Trials|September 19, 2014
Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?James M S Wason, Lynne Stecher, Adrian P Mander
Plos One|July 13, 2016
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical TrialsGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Clinical Trials (London, England)|June 28, 2017
Group sequential designs for stepped-wedge cluster randomised trialsMichael J Grayling, James Ms Wason, Adrian P Mander
Journal of the Royal Statistical Society. Series C, Applied Statistics|March 19, 2019
A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity dataGraham M Wheeler, Michael J Sweeting, Adrian P Mander
Pageof 8